Icon-personalized-medicine
CPT CodeDescription
81225Cyp2c19 Gene Analysis Common Variants
81226Cyp2d6 Gene Analysis Common Variants
81227Cyp2c9 Gene Analysis Common Variants
81355Vkorc1 Gene Analysis Common Variant(S)
81401Molecular Pathology Procedure Level 2 A4/A5
81401Molecular Pathology Procedure Level 2 A4/A4
81479Unlisted Molelcular Pathology Procedure
81350Ugt1a1 Gene Analysis Common Variants
81400Molecular Pathology Procedure Level 1
81400Molecular Pathology Procedure Level 1
81479DPYD
81231Molecular Pathology Procedure Level 2 A4/A5
81230Molecular Pathology Procedure Level 2 A4/A4
81232DPYD
81328SLCO1B1

CDR Labs offers a comprehensive pharmacogenomics panel to help identify mutations that may affect a person’s metabolism and/or response to medications. Using a simple cheek swab and our 34 gene panel, our team identifies mutations that may affect a person’s drug metabolism and/or response to medications. Our pharmacists then review the patient’s current medications and the pharmacogenetic data to detect drug-to-drug and drug-to gene interactions. The report also includes a Medication Summary, a list of medications with evidence for the use of pharmacogenetic information, organized by their associated conditions. Medications are also organized based on drug-gene interactions. In this manner, Physicians can consider the information contained in the Medication Report before making any clinical or therapeutic decisions. Each report also includes an annotated guide to how to use and interpret the report.

Genes Included in the Panel

  • ABCB1
  • ABCC2
  • ABCG2
  • CYP1A1
  • CYP1A2
  • CYP2A6
  • CYP2B6
  • CYP2C19
  • CYP2C8
  • CYP2C9
  • CYP2D6
  • CYP2E1
  • CYP3A4
  • CYP3A5
  • DPYD
  • GSTP1
  • NAT1
  • NAT2
  • SLC15A2
  • SLC22A1
  • SLC22A2
  • SLC22A6
  • SLCO1B1
  • SLCO1B3
  • SLCO2B1
  • TPMT
  • UGT1A1
  • UGT2B15
  • UGT2B7
  • VKORC1